Optimization and Certification of Drug and Gene Delivery Pla

The Florida Department of Health has awarded a grant to the University of South Florida under the Florida Cancer Innovation Fund for a project titled Optimization and Certification of Drug and Gene Delivery Platform Toward Clinical Translation and Commercialization. Led by Principal Investigator Richard Heller, this initiative focuses on advancing innovative cancer-related research, emerging trends, and promising practices to serve as a catalyst for further exploration and commercialization. The contract, identified by solicitation number 26C27, has an original award amount of 1,685,286.73 dollars and is scheduled to begin on August 1, 2026. This funding is part of a broader state effort to support one-year cancer research projects within Florida, requiring grantees to adhere to specific reporting and performance standards to ensure the successful translation of research into clinical applications.